GV

Girija Venkateswarakumar Meenakshi

Active Director Director DIN 11013081
DIN 11013081 First appointment Mar 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Girija Venkateswarakumar Meenakshi

Data last updated:

Girija Venkateswarakumar Meenakshi is a Director at Ram Pharma Needs Private Limited (since 2025).

DIN 11013081
Primary Designation Director
First Appointment 21 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ram Pharma Needs Private Limited U46497TZ2025PTC034041
Director21 Mar 20252025Active

Board colleagues of Girija Venkateswarakumar Meenakshi

NameDINCompanyDesignation
Sivaraman Meyyappan10275659Ram Pharma Needs Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ram Pharma Needs Private Limited
Premium access

Shareholding and investment profile for Girija Venkateswarakumar Meenakshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Girija Venkateswarakumar Meenakshi

Girija Venkateswarakumar Meenakshi currently holds 1 directorship: Ram Pharma Needs Private Limited (Director, since 21 Mar 2025).

Girija Venkateswarakumar Meenakshi was first appointed on 21 Mar 2025 as Director at Ram Pharma Needs Private Limited.

The current boards of Girija Venkateswarakumar Meenakshi's companies include Sivaraman Meyyappan (Ram Pharma Needs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available